CXA-101 (IV)

CXA-101 · Cubist Pharmaceuticals LLC (a Merck & Co. subsidiary)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CXA-101 (IV), covering 2015-01-15 to 2015-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections [Phase 2]

See pricing